$ cat ./records/gates-foundation-becomes-founding-philanthropic-donor-to-world-ba-2022.txt
Gates Foundation Becomes Founding Philanthropic Donor to World Bank Pandemic Fund at G20 Bali
[RECORD.TXT] · cat --full
In November 2022, the Gates Foundation joined 25 sovereign and philanthropic contributors as a founding donor to the World Bank's Pandemic Fund — the first multilateral financing mechanism dedicated exclusively to pandemic prevention, preparedness, and response grants in LMICs, launched under Indonesia's G20 Presidency at Bali. The Gates Foundation holds a seat on the fund's governing board and contributed $15 million in seed capital. The Pandemic Fund's first grant round allocated $338 million across dozens of countries for disease surveillance, laboratory systems, and health workforce strengthening.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Pledges $912 Million to Global Fund — Largest-Ever Commitment to Fight HIV, TB, and Malaria by 2030
Next →
Gates-Backed CEPI Launches $50 Million Funding Call for Rift Valley Fever Vaccine Phase Trials in Africa
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.